Search

everythinglearnresearchcommunity

for

Search:↓

A genetic mutation linked to longer life and less disease was found in the Amish, and a drug is being developed to replicate these benefits.

Genetically modifying a bacteria and changing its growth conditions significantly increased the production of a chemical called dipicolinic acid.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

3D bioprinting shows promise for better skin regeneration by creating structures similar to natural skin.

Organoid technology helps create mini-organs for studying diseases and testing drugs.

A new tool allows easier long-term imaging of live skin cells, helping study diseases like skin cancer.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

The Automatic Biofibre® Hair Implant is a fast and effective hair restoration method that provides immediate cosmetic benefits and good results in over 90% of cases, but requires proper care to avoid complications.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

New biofabrication technologies could lead to treatments for hair loss.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Bio-enhanced hair restoration, using methods like growth factors, stem cells, and ATP, results in better hair growth and density than traditional hair transplants.

Developing microRNA-based treatments is hard but has potential.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

RNAi-based biopesticides could be safe and effective for pest control with careful development and risk assessment.

A new method, iSiMPRe, effectively identifies key protein regions in cancer genes, highlighting potential drug targets.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Vitamin B12 improves the health and growth of hair micrografts.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

3D bioprinting in plastic surgery could lead to personalized grafts and fewer complications.

3D bioprinting could improve skin repair and treat conditions like vitiligo and alopecia by precisely placing cells.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Portable point-of-care testing can improve quick and accurate genetic disorder detection.